Top Qs
Timeline
Chat
Perspective
HIPRA
Spanish pharmaceutical company From Wikipedia, the free encyclopedia
Remove ads
HIPRA is a biotech pharmaceutical company headquartered in Amer, Catalonia, Spain focused on prevention for animal and human health, with a product base of vaccines and diagnostic services.[1]
 | This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these messages)
|
HIPRA has an international presence in 40 countries with its own subsidiaries, 3 R&D centres and production plants located in Europe (Spain) and America (Brazil).[2]
In addition, its international distribution network maintains open distribution channels with more than 100 countries, covering all 5 continents.[3]
Since 2020, the company has been developing a vaccine against COVID-19.[4]
Remove ads
History
Summarize
Perspective
HIPRA got founded in 1971, in a small laboratory in Madrid.[5] The name HIPRA comes from the surnames of its former creators: Hidalgo and Prada.
In 1991 HIPRA had a workforce of 100 people and a turnover of 10 million euros, it was an important year in HIPRA's history, with a new management team, and a redefined company expansion policy.[2]
In the year 2000, the company began internationalization, beginning the implementation of its own subsidiaries around the world.[5] Currently HIPRA has commercial subsidiaries in 40 countries. It also has 3 research centers and 6 production plants located in Europe and America.[2]
In 2009 HIPRA began to focus on prevention; therefore, it stopped investing in pharmacological products.[5]
In 2021 the new Human Health division was created by HIPRA to create new products.[6] The same year, GoodGut was acquired by HIPRA, a biotechnological start-up dedicated to the research and development of diagnostic tests for digestive diseases.[7]
In the wake of the Covid-19 pandemic, HIPRA decided to branch out from its traditional veterinary medicine market to develop the country's first Covid-19 vaccine. The vaccine developed by HIPRA is an adjuvanted recombinant protein vaccine based on a receptor-binding domain (RBD) fusion heterodimer containing the alpha and beta variants of SARS-CoV-2.[8]
In June 2022, the Generalitat of Catalonia awarded HIPRA the Creu de Sant Jordi for "its involvement in the research of a new vaccine against the disease caused by the SARS-CoV-2 virus" and for its "commitment to the country's public health."[9]
Remove ads
Animal health
HIPRA has developed more than 100 vaccines for different animal species, both production and companion animals, against a wide variety of biological targets. In addition to its Amer plant, the company has another plant in Brazil, in the Porto Alegre conurbation. It also has a university research centre in the United States.[10]
HIPRA's animal health products include vaccines, vaccination devices,[11] integrated traceability services and diagnostic kits.
Remove ads
External links
- hipra.com Archived 2022-09-29 at the Wayback Machine, company website
References
Wikiwand - on
Seamless Wikipedia browsing. On steroids.
Remove ads